- STAT+: Pharmalittle: We’re reading about FDA commissioner contenders, a heart drug failure, and moreThe White House is reviewing a list of three top contenders for the FDA commissioner postSTAT · 17d ago↗ source
- STAT+: OpenEvidence backs study that finds it beats LLMsIn this edition of STAT Health Tech: Dueling research pitting OpenEvidence against general purpose LLMs, use of Dexcom's CGM in children, and more.STAT · 17d ago↗ source
- HHS plan to speed drug research won’t remove ‘self-inflicted’ delays<figure><div><img src="https://imgproxy.divecdn.com/CBRbv7ysPGDg2gR4-a3jhbQNYceSmw-Eq03sjZFRhY4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTk2ODIwNDM5LmpwZ…